Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Massively parallel digital transcriptional profiling of single cells.

Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J, Gregory MT, Shuga J, Montesclaros L, Underwood JG, Masquelier DA, Nishimura SY, Schnall-Levin M, Wyatt PW, Hindson CM, Bharadwaj R, Wong A, Ness KD, Beppu LW, Deeg HJ, McFarland C, Loeb KR, Valente WJ, Ericson NG, Stevens EA, Radich JP, Mikkelsen TS, Hindson BJ, Bielas JH.

Nat Commun. 2017 Jan 16;8:14049. doi: 10.1038/ncomms14049.

2.

Editorial overview: Molecular and genetic bases of disease.

Suzuki CK, Bielas JH.

Curr Opin Genet Dev. 2016 Jun;38:iv-vi. doi: 10.1016/j.gde.2016.09.001. No abstract available.

PMID:
27680305
3.

Mitochondrial DNA exhibits resistance to induced point and deletion mutations.

Valente WJ, Ericson NG, Long AS, White PA, Marchetti F, Bielas JH.

Nucleic Acids Res. 2016 Oct 14;44(18):8513-8524.

4.

Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.

Bianchi-Frias D, Basom R, Delrow JJ, Coleman IM, Dakhova O, Qu X, Fang M, Franco OE, Ericson NG, Bielas JH, Hayward SW, True L, Morrissey C, Brown L, Bhowmick NA, Rowley D, Ittmann M, Nelson PS.

Mol Cancer Res. 2016 Apr;14(4):374-84. doi: 10.1158/1541-7786.MCR-15-0330.

PMID:
26753621
5.

Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.

Haider M, Zhang X, Coleman I, Ericson N, True LD, Lam HM, Brown LG, Ketchanji M, Nghiem B, Lakely B, Coleman R, Montgomery B, Lange PH, Roudier M, Higano CS, Bielas JH, Nelson PS, Vessella RL, Morrissey C.

Clin Exp Metastasis. 2016 Mar;33(3):239-48. doi: 10.1007/s10585-015-9773-7.

PMID:
26667932
6.

The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition.

Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA, Devi A, Detraux D, Gu H, Battle SL, Showalter M, Valensisi C, Bielas JH, Ericson NG, Margaretha L, Robitaille AM, Margineantu D, Fiehn O, Hockenbery D, Blau CA, Raftery D, Margolin AA, Hawkins RD, Moon RT, Ware CB, Ruohola-Baker H.

Nat Cell Biol. 2015 Dec;17(12):1523-35. doi: 10.1038/ncb3264.

7.

Targeted single molecule mutation detection with massively parallel sequencing.

Gregory MT, Bertout JA, Ericson NG, Taylor SD, Mukherjee R, Robins HS, Drescher CW, Bielas JH.

Nucleic Acids Res. 2016 Feb 18;44(3):e22. doi: 10.1093/nar/gkv915.

8.

Subacute calorie restriction and rapamycin discordantly alter mouse liver proteome homeostasis and reverse aging effects.

Karunadharma PP, Basisty N, Dai DF, Chiao YA, Quarles EK, Hsieh EJ, Crispin D, Bielas JH, Ericson NG, Beyer RP, MacKay VL, MacCoss MJ, Rabinovitch PS.

Aging Cell. 2015 Aug;14(4):547-57. doi: 10.1111/acel.12317.

9.

Skeletal muscle mitochondrial DNA deletions are not increased in CuZn-superoxide dismutase deficient mice.

Wanagat J, Ahmadieh N, Bielas JH, Ericson NG, Van Remmen H.

Exp Gerontol. 2015 Jan;61:15-9. doi: 10.1016/j.exger.2014.11.012.

10.

Response to: 'when man got his mtDNA deletions?'.

Taylor SD, Salk JJ, Bielas JH.

Aging Cell. 2014 Aug;13(4):583. doi: 10.1111/acel.12230. No abstract available.

11.

Digital genomic quantification of tumor-infiltrating lymphocytes.

Robins HS, Ericson NG, Guenthoer J, O'Briant KC, Tewari M, Drescher CW, Bielas JH.

Sci Transl Med. 2013 Dec 4;5(214):214ra169. doi: 10.1126/scitranslmed.3007247.

12.

High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer.

Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, Drescher CW, Tewari M, Bielas JH, Robins HS.

J Pathol. 2013 Dec;231(4):433-40. doi: 10.1002/path.4260.

13.

Simultaneous digital quantification and fluorescence-based size characterization of massively parallel sequencing libraries.

Laurie MT, Bertout JA, Taylor SD, Burton JN, Shendure JA, Bielas JH.

Biotechniques. 2013 Aug;55(2):61-7. doi: 10.2144/000114063.

14.

Targeted enrichment and high-resolution digital profiling of mitochondrial DNA deletions in human brain.

Taylor SD, Ericson NG, Burton JN, Prolla TA, Silber JR, Shendure J, Bielas JH.

Aging Cell. 2014 Feb;13(1):29-38. doi: 10.1111/acel.12146.

15.

Heterogeneity of tumor-induced gene expression changes in the human metabolic network.

Hu J, Locasale JW, Bielas JH, O'Sullivan J, Sheahan K, Cantley LC, Vander Heiden MG, Vitkup D.

Nat Biotechnol. 2013 Jun;31(6):522-9. doi: 10.1038/nbt.2530.

16.

Decreased mitochondrial DNA mutagenesis in human colorectal cancer.

Ericson NG, Kulawiec M, Vermulst M, Sheahan K, O'Sullivan J, Salk JJ, Bielas JH.

PLoS Genet. 2012;8(6):e1002689. doi: 10.1371/journal.pgen.1002689.

17.

Aging neural progenitor cells have decreased mitochondrial content and lower oxidative metabolism.

Stoll EA, Cheung W, Mikheev AM, Sweet IR, Bielas JH, Zhang J, Rostomily RC, Horner PJ.

J Biol Chem. 2011 Nov 4;286(44):38592-601. doi: 10.1074/jbc.M111.252171.

18.

Roles of DNA polymerase I in leading and lagging-strand replication defined by a high-resolution mutation footprint of ColE1 plasmid replication.

Allen JM, Simcha DM, Ericson NG, Alexander DL, Marquette JT, Van Biber BP, Troll CJ, Karchin R, Bielas JH, Loeb LA, Camps M.

Nucleic Acids Res. 2011 Sep 1;39(16):7020-33. doi: 10.1093/nar/gkr157.

19.

A random mutation capture assay to detect genomic point mutations in mouse tissue.

Wright JH, Modjeski KL, Bielas JH, Preston BD, Fausto N, Loeb LA, Campbell JS.

Nucleic Acids Res. 2011 Jun;39(11):e73. doi: 10.1093/nar/gkr142.

20.

Generation, function, and prognostic utility of somatic mitochondrial DNA mutations in cancer.

Kulawiec M, Salk JJ, Ericson NG, Wanagat J, Bielas JH.

Environ Mol Mutagen. 2010 Jun;51(5):427-39. doi: 10.1002/em.20582. Review.

PMID:
20544883
Items per page

Supplemental Content

Loading ...
Support Center